Literature DB >> 17981211

Isochromosome (X)(p10) in hematologic disorders: FISH study of 14 new cases show three types of centromere signal patterns.

Adewale Adeyinka1, Stephanie Smoley, Stephanie Fink, Jessica Sanchez, Daniel L Van Dyke, Gordon Dewald.   

Abstract

Though X chromosome anomalies are uncommon in hematologic malignancies, isodicentric X chromosomes, idic(X)(q13), with break and fusion points at Xq13 are well known among older females with de novo myelodysplasia. In contrast, only 17 patients with X isochromosomes involving break and fusion points at the centromere i(X)(p10) have been published, to our knowledge. We present 14 new patients with i(X)(p10) identified by G-banding and further characterized by fluorescence in situ hybridization (FISH) using probes for the X p-arm, X alpha-satellite DNA (DXZ1), and the XIST gene (Xq13). These anomalies each had an X p-arm probe signal on either side of a single centromeric FISH signal, thus they are monocentric isochromosomes. On the basis of FISH, the following three centromeric patterns were identified: (1) centromere signal same size as normal X, (2) centromere signal larger than normal X, and (3) centromere signal smaller than normal X. These centromere patterns may be related to the mechanism of i(X)(p10) formation. In 9 (64%) of 14 patients, the i(X)(p10) was the sole anomaly, attesting to its pathogenic potential. Our series, when collated with information on previously reported cases of i(X)(p10), show that this anomaly is associated with females with a median age 74 years, though patients from 3.75 to 49 years, including a 17-year-old in the present cohort, have been described. i(X)(p10) is observed in a wide range of hematologic malignancies, including myeloid and lymphoid disorders, as well as a patient with therapy-related AML in the present series. i(X)(p10) has been reported in occasional males, indicating that this anomaly can arise from active X chromosomes. It is not known whether i(X)(p10) arises randomly from the active or inactive X chromosome in female patients.

Entities:  

Mesh:

Year:  2007        PMID: 17981211     DOI: 10.1016/j.cancergencyto.2007.07.011

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

1.  Identification of i(X)(p10) as the sole molecular abnormality in atypical chronic myeloid leukemia evolved into acute myeloid leukemia.

Authors:  Carmelo Gurnari; Paola Panetta; Emiliano Fabiani; Anna Maria Nardone; Diana Postorivo; Giulia Falconi; Luca Franceschini; Manuela Rizzo; Vito Mario Rapisarda; Eleonora De Bellis; Francesco Lo-Coco; Maria Teresa Voso
Journal:  Mol Clin Oncol       Date:  2017-12-29

2.  Atypical chronic myeloid leukemia with isochromosome (X)(p10): A case report.

Authors:  Masahide Yamamoto; Sayaka Suzuki; Jun-Ichi Mukae; Keisuke Tanaka; Ken Watanabe; Gaku Oshikawa; Tetsuya Fukuda; Naomi Murakami; Osamu Miura
Journal:  Oncol Lett       Date:  2017-07-18       Impact factor: 2.967

3.  A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide.

Authors:  Sheng Wei; Xianghong Chen; Kathy Rocha; P K Epling-Burnette; Julie Y Djeu; Qing Liu; John Byrd; Lubomir Sokol; Nick Lawrence; Roberta Pireddu; Gordon Dewald; Ann Williams; Jaroslaw Maciejewski; Alan List
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-26       Impact factor: 11.205

4.  A novel unbalanced de novo translocation der(5)t(4;5)(q26;q21.1) in adult T-cell precursor lymphoblastic leukemia.

Authors:  Eigil Kjeldsen; Anne Stidsholt Roug
Journal:  Mol Cytogenet       Date:  2012-05-01       Impact factor: 2.009

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.